Effects of the 24 N-terminal amino acids of p55PIK on endotoxinstimulated release of inflammatory cytokines by hacat cells

Abstract

This study aimed to examine the effect of the 24 N-terminal amino acids (N24) of p55PIK, a regulatory subunit of phosphatidylinositol 3-kinase (PI3K), on the endotoxin lipopolysaccharide (LPS)-stimulated release of the cytokines (CKs) by HaCaT cells. The fusion protein, trans-acting activator of transcription (TAT)-N24 (an experimental peptide, EP) containing the N24 of PI3K-p55PIK, was constructed, and TAT-N24 fusion peptide was expressed and identified in BL21 E·coli. HaCaT cells (a human keratinocyte cell line) was cultured and stimulated by LPS at 100 ng/mL for 1, 2, 4, 8, 16 or 24 h, or by LPS at 10, 100 ng/mL, 1, 10 or 100 μg/mL of for 4 h. Changes in the protein and mRNA levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8) released by HaCaT cells following EP intervention were determined by enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (PCR). Immunofluorescence confocal laser scanning microscopy was utilized to detect the protein expression and translocation of the p65 subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB p65) in HaCaT cells. The expression of the NF-κB inhibitor alpha (IκB-α) protein in LPS-stimulated HaCaT cells after the EP intervention was measured by Western blotting. The results showed that EP treatment increased TNF-α secretion from HaCaT cells. EP at certain concentrations could effectively inhibit the LPS-stimulated release of TNF-α, IL-6 and IL-8 from HaCaT cells. The ELISA assay demonstrated that the concentrations of TNF-α, IL-6 and IL-8 in the supernatants of LPS-stimulated cells were reduced from 208.06±30.18, 86.4±9.78 and 260.59±54.05 pg/mL to 121.78±22.26, 53.18±7.36 and 125.08±35.17 pg/mL, respectively, in the supernatants of cells treated by LPS and EP combined. Real-time PCR also revealed that the expression of the three pro-inflammatory CKs was significantly decreased after EP intervention. Immunofluorescence confocal laser scanning microscopy showed that NF-κB p65 protein was primarily expressed in the cytoplasm of non-stimulated HaCaT cells. After LPS stimulation, NF-κB p65 was translocated into the nucleus, and the nuclear expression of this protein increased. The nuclear NF-κB p65 protein expression was inhibited after the addition of EP. Western blotting showed that IκB-α expression began to decrease 30 min after LPS stimulation and declined to a trough 4 h later. IκB-α expression began to gradually recover 16 h after LPS stimulation but remained at a lower-than-normal level at 24 h. Greater IκB-α expression was found in cells treated with LPS and EP combined than those treated with LPS alone. It was concluded that EP can effectively inhibit the LPS-stimulated expression of TNF-α, IL-6, and IL-8, which involves the inhibition of the hydrolysis of IκB-α and thereby blockage of the nuclear translocation of NF-κB p65.

Keywords

phosphatidylinositol 3-kinase / lipopolysaccharide / tumor necrosis factor / interleukin-6 / interleukin-8

References

[1] BosJD, De RieMA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today, 1999, 20(1): 40-46

[2] CooperKD, HammerbergC, BaadsgaardO, et al.. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol, 1990, 144(12): 4593-4603

[3] GomiT, ShioharaT, MunakataT, et al.. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol, 1991, 127(6): 827-830

[4] NeunerP, UrbanskiA, TrautingerF, et al.. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol, 1991, 97(1): 27-33

[5] KondoS, KonoT, SauderDN, et al.. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol, 1993, 101(5): 690-694

[6] SchulzBS, MichelG, WagnerS, et al.. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol, 1993, 151(8): 4399-4406

[7] LugerT A, SchwarzT. Evidence for an epidermal cytokine network. J Invest Dermatol, 1990, 95(6Suppl): 100S-104S

[8] GilharA, PillarT, EtzioniA. Possible role of cytokines in cellular proliferation of the skin transplanted onto nude mice. Arch Dermatol, 1995, 131(1): 38-42

[9] SteinM, BerndA, Ramirez-BoscaA, et al.. Measurement of anti-inflammatory effects of glucocorticoids on human keratinocytes in vitro. Comparison of normal human keratinocytes with the keratinocyte cell line HaCaT. Arzneimittelforschung, 1997, 47(11): 1266-1270

[10] WangGH, SunL, DengY, et al.. Expression and identification of cell-permeable TAT-N24 fusion peptide. Acta Med Univ Sci Technol Huazhong(Chinese), 2010, 39(2): 175-178

[11] OkkenhaugK, BilancioA, FarjotG, et al.. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science, 2002, 297(5583): 1031-1034

[12] AkiraS. Toll-like receptors and innate immunity. Adv Immunol, 2001, 78: 1-56

[13] IwasakiA, MedzhitovR. Toll-like receptor control of the adaptive immune responses. Nat Immunol, 2004, 5(10): 987-995

[14] KondoS, KonoT, SauderDN, et al.. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol, 1993, 101(5): 690-694

[15] SchulzB S, MichelG, WagnerS, et al.. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol, 1993, 151(8): 4399-4406

[16] GillitzerR, BergerR, MielkeV, et al.. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol, 1991, 97(1): 73-79

[17] SuSB, SilverPB, GrajewskiRS, et al.. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol, 2005, 175(10): 6303-6310